Head-to-head · Cost-Efficiency Index
Claya vs Dollar Dad Club
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Claya
Cost-first shoppers who want a same-price-any-dose semaglutide plan, for shoppers willing to consider a multi-month prepay to get the advertised rate.
Visit ClayaDollar Dad Club
Shoppers willing to read past the homepage headline to the product page's actual terms in exchange for named, license-numbered prescribers.
Visit Dollar Dad ClubThe verdict
Claya and Dollar Dad Club tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Claya (ranked #97, a hair above #98) — Cost-first shoppers who want a same-price-any-dose semaglutide plan, for shoppers willing to consider a multi-month prepay to get the advertised rate. But Dollar Dad Club is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Claya.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Claya | Dollar Dad Club |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $149/mo (all doses, compounded) | $129/mo (all doses, compounded) |
| Tirzepatide / mo | $199/mo (starting dose, compounded) | $129/mo |
| Semaglutide / yr (modeled) | $1,788 | $1,548 |
| Tirzepatide / yr (modeled) | $2,388 | $1,548 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #97 | #98 |
Claya
69/100Where the value is
- Semaglutide is explicitly 'same price regardless of dosage' at $149/mo, removing dose-tier guesswork
- LegitScript Certified, BBB Accredited, and HIPAA Compliant badges all displayed together
- '$100 off your first month' promo code (100CLAYA) published openly with no intake required to see it
The tradeoffs
- The advertised $149/$199 rates are qualified elsewhere on the same page as available 'with select multi-month plans' — a shopper reading only the 'a month' headline could reasonably assume pure month-to-month billing when a prepay term may be required
- No state coverage list is published anywhere on the public site
Dollar Dad Club
69/100Where the value is
- Genuinely names individual licensed prescribers with license numbers by state (Dr. Jeffrey Shellenberger — CA #C160558, MA #290752, VT #042.0015585-COMP; Dr. Marc Serota — RI #MA17024), rarer transparency than most competitors in this batch
- Claims all-50-state coverage
- Both an injectable (semaglutide/tirzepatide, same price) and an oral semaglutide option are offered on one platform
The tradeoffs
- The homepage's headline prices do not reconcile with the product pages' own numbers: '$89/month' injectable matches no total shown anywhere (real totals are $599-$899 for a 6-month plan), and '$149/month' oral is a 3-month-prepay, promo-code, lowest-dose-only rate whose true 1-month price at that dose is $449 — three times the headline
- No compounding pharmacy named, only generic 'leading U.S.-based compounding pharmacies'
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.